| Ashfaq Ahmed Razzaq, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 731-9701 | |
| (205) 297-9411 |
| Full Name | Ashfaq Ahmed Razzaq |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841550076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 3602 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashfaq Ahmed Razzaq, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Ashfaq Ahmed Razzaq, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 731-9701 |
News Archive
Chromogenex US, Inc., of Howell, Michigan, the sister company of Chromogenex Technologies, Ltd., and LiLa Enterprise, LLC of Suwanee, Georgia, announced today a strategic alliance wherein Chromogenex US appoints LiLa the exclusive distributor for the i- lipo and i-lipo Ultra body sculpting systems that employ low level laser technology for smoothing cellulite, fat reduction and body shaping treatments.
Mood disorders, including depression, are the most common comorbid conditions in individuals with epilepsy, but the cause remains unclear, according to a latest study by researchers at Columbia University's Mailman School of Public Health and Rutgers University.
Senior Housing Properties Trust today announced that the underwriters of its secondary offering have exercised, in full, their over-allotment option to purchase an additional 1,875,000 shares of beneficial interest, raising additional net proceeds of approximately $36.8 million. The settlement of the over-allotment option is expected to occur on December 15, 2010.
Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.
› Verified 5 days ago
James Russell Bowman, M.D./ PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 200, Birmingham, AL 35205 Phone: 205-933-7838 | |
Jan Kenjiro Vonhoegen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 Montclair Rd, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5220 | |
Victoria Masear, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Medical Park E Dr, Suite 200, Birmingham, AL 35235 Phone: 205-838-3090 Fax: 205-838-6783 | |
Abhinav Agarwal, M.B.B.S. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S Fl 3, Birmingham, AL 35233 Phone: 205-801-8630 Fax: 205-975-9532 | |
Stephen Patrick Cowley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 720 Montclair Rd, Suite101, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5210 | |
Chong Weng, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 20th St S, Birmingham, AL 35233 Phone: 205-930-8339 | |
Patrick Reid Peavy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 |